The Pharmafocus Interview: John Patterson
December 19, 2007Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations
John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Delayed Galvus cleared for 2008 European launch
December 19, 2007Sales and Marketing EU, diabetes
A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …
Cervarix US approval delayed
December 19, 2007Research and Development, Sales and Marketing
GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …
Novartis to make new round of job cuts
December 19, 2007Sales and Marketing
Novartis will cut around 2,500 jobs as part of a new streamlining programme that aims to save $1.6 billion by …
Northbank joins communications consultancy College Hill
December 19, 2007Medical Communications
Northbank Communications has been acquired by College Hill, in a deal that will extend its international reach and add new …
Latest news from Datamonitor
December 18, 2007Research and Development
BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …
NICE and Novartis work on groundbreaking pilot
December 18, 2007Sales and Marketing
NICE could provide early advice to pharma companies on the data it requires for its appraisals, if a new pilot …
Providing training to the NHS: a learning curve for pharma too
December 18, 2007Sales and Marketing NHS, pharma, training
It hardly needs to be said that each wave of NHS reorganisation has brought new challenges in terms of pharma …
Eisai signs $3.9bn biotech deal
December 14, 2007Research and Development, Sales and Marketing Eisai
Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
Costly private practices will not improve service, warns BMA
December 14, 2007The government's pledge to build 100 new practices in under-doctored areas could make health inequalities in Britain even worse, according …
Bayer Schering blood clotting drug a ‘major leap forward’
December 14, 2007Sales and Marketing Bayer, Xarelto, clot
Bayer Schering says its new blood clotting drug Xarelto is poised to set a new standard of care for post-surgery …
GSK boosts portfolio in cancer and anti-infectives
December 14, 2007Research and Development
GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …
NICE bends to pressure over Lucentis
December 14, 2007Sales and Marketing AMD, Lucentis, NICE
NICE is set to change its guidance for blindness treatment Lucentis following a barrage of complaints over its failure to …
Get ready for inspection
December 13, 2007Research and Development MHRA, inspection, reg affairs
No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …
Herefordshire pioneers PCT and council merger
December 12, 2007Sales and Marketing
A revolutionary new 'public service trust' has been created in Herefordshire, and will be the first to integrate a PCT …
Supply chain could inflate prices, says watchdog
December 12, 2007Sales and Marketing
The NHS could face steeper prices on drugs due to manufacturers adopting a new restrictive distribution model, according to a …
Stout to quit as GSK restructures
December 10, 2007Sales and Marketing GSK, restructure
GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …
Pharma calls for European ‘patient information partnerships’
December 10, 2007Medical Communications
Pharmaceutical industry leaders are hoping that 2008 will see a breakthrough on one of the most contentious issues in European …
Avandia suffering less in Europe
December 10, 2007Sales and Marketing Avandia, diabetes
New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …
GP leader hits out at regulator’s demands
December 10, 2007Sales and Marketing
The chairman of the NHS Alliance has criticised a new report which says GPs are not carrying out 'basic work' …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
